Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
32.80    0.10 (0.31%)
Bid:
32.60
Ask:
33.00
Spread: 0.40 (1.227%)
Market Cap: £24.08m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

AGM Statement

3 Sep 2015 07:00

RNS Number : 9155X
Carclo plc
03 September 2015
 

 

3 September 2015

 

Carclo plc

("Carclo" or the "Group")

 

AGM Statement

The board is pleased to announce that the Group has continued to perform strongly during the second quarter and trading remains in line with its expectations for the year ending 31 March 2016.

Technical Plastics has had a good start to the year. The implementation of our expansion strategy has continued with the new Chinese factory on course to commence manufacturing within the next few weeks. Our successful drive to improve operational efficiency has so far reduced the impact of the weaker Euro, helping to preserve margins in line with the board's expectations.

LED Technologies has been successful in managing the large number of new programmes that it has secured over recent years for new lighting systems from its luxury and supercar customers. Some of these are now transitioning, as expected, to prototyping and production phases. New programme wins have continued in line with our expectations. General lighting product sales have also been strong. As a whole, we currently expect the division to deliver a stronger trading performance for the year than previously anticipated.

Our Precision Engineering Aerospace business has also seen a solid performance in the first half of the financial year. We have recently experienced some weakness in the spares segment order book and, whilst this may recover in the second half, the divisional trading result is expected to be a little behind our previous expectations for the year as a whole.

Carclo Diagnostic Solutions has continued to meet its technical timelines. During the second half of the year it will increase customer and partner interactions and this will assist in providing a validation of the technology prior to moving to further phases of investment.

The Group's financing remains strong and, as expected following the investment in China, Group debt will increase slightly at the half year ending 30 September 2015, before reducing in line with expectations by the end of the financial year.

The board continues to have a strong level of confidence in the future performance of the Group.

- ENDS -

 

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Jock Maxwell Macdonald

 

 

Mike Bell

 

 

 

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

 

Note to Editors

 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the group has been investing in lower cost regions and new technologies.

 

Approximately three fifths of revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSSWFMEFISELU
Date   Source Headline
15th Jun 201011:07 amRNSDirector/PDMR Shareholding
10th Jun 20109:25 amRNSDirector/PDMR Shareholding
8th Jun 20107:00 amRNSFinal Results
24th May 201010:02 amRNSHolding(s) in Company
7th May 20104:49 pmRNSHolding(s) in Company
8th Apr 20107:00 amRNSPre-close trading statement
7th Apr 20103:30 pmRNSCDT and CIT demonstrate ITO-Free lighting panel
31st Mar 201010:19 amRNSHolding(s) in Company
22nd Mar 20104:27 pmRNSHolding(s) in Company
2nd Mar 20104:07 pmRNSHolding(s) in Company
25th Feb 20107:00 amRNSHolding(s) in Company
11th Feb 20107:00 amRNSInterim Management Statement
3rd Feb 20101:27 pmRNSHolding(s) in Company
2nd Feb 201012:41 pmRNSHolding(s) in Company
8th Jan 20109:26 amRNSHolding(s) in Company
4th Jan 20102:32 pmRNSTotal Voting Rights
4th Jan 20102:29 pmRNSHolding(s) in Company
4th Jan 20101:31 pmRNSHolding(s) in Company
24th Dec 200911:34 amRNSHolding(s) in Company
23rd Dec 20093:04 pmRNSHolding(s) in Company
22nd Dec 20092:06 pmRNSHolding(s) in Company
22nd Dec 20091:22 pmRNSHolding(s) in Company
17th Dec 20093:43 pmRNSPerformance Share Plan Award
16th Dec 20092:22 pmRNSDirector/PDMR Shareholding
16th Dec 200912:49 pmRNSDirector/PDMR Shareholding
16th Dec 20097:00 amRNSIssue of Equity
8th Dec 20097:00 amRNSAgreement with Atmel Corporation
24th Nov 20097:00 amRNSHalf Yearly Report
2nd Oct 20097:00 amRNSHalf Year Trading Update
4th Sep 20091:13 pmRNSResult of AGM
3rd Sep 20091:53 pmRNSHolding(s) in Company
13th Aug 20097:00 amRNSInterim Management Statement
12th Aug 20091:29 pmRNSHolding(s) in Company
30th Jul 20094:11 pmRNSHolding(s) in Company
1st Jul 20091:49 pmRNSHolding(s) in Company
24th Jun 20094:07 pmRNSDirector/PDMR Shareholding
9th Jun 20097:00 amRNSFinal Results
7th Apr 20097:00 amRNSPre-close trading update
4th Feb 20097:00 amRNSInterim Management Statement
21st Jan 20095:09 pmRNSDirectors's disclosure update
5th Dec 20082:13 pmRNSDirector/PDMR Shareholding
25th Nov 20087:00 amRNSInterim Results
25th Sep 20087:00 amRNSHalf year trading update
5th Sep 20089:39 amRNSResult of AGM
19th Aug 20087:00 amRNSInterim Management Statement
8th Aug 20083:01 pmRNSApproval for Xennia sale of C
16th Jun 20083:36 pmRNSDirector/PDMR Shareholding
10th Jun 20087:00 amRNSFinal Results
22nd May 200810:00 amRNSNotice of Results
8th Apr 20087:01 amRNSPre-Close Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.